Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Results symbols : NVS save search
Erasca Reports Fourth Quarter 2023 and Full Year 2023 Business Updates and Financial Results
Published: 2024-03-27 (Crawled : 20:00) - globenewswire.com
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
ERAS | $1.795 -2.45% -2.51% 650K
|
|
| O: 17.48%
H: 6.94%
C: -14.88%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.52%
H: 0.0%
C: 0.0%
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.28%
H: 1.71%
C: -0.3%
business year financial results
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update
Published: 2024-03-27 (Crawled : 11:00) - biospace.com/
CRBU | $3.91 0.0% 1.4M
|
Health Technology
|
| O: 1.58%
H: 0.58%
C: -0.39%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.24%
H: 0.42%
C: 0.4%
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.49%
H: 0.84%
C: -0.07%
TGTX | $14.0 1.3% 1.29% 3.5M
|
Health Technology
|
| O: 0.71%
H: 0.39%
C: 0.13%
DTIL | $10.77 -6.43% -6.87% 71K
|
Health Technology
|
| O: 0.39%
H: 4.22%
C: 1.41%
precision business year update financial results
MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-03-13 (Crawled : 23:00) - biospace.com/
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: 0.0%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.07%
H: 0.09%
C: -0.7%
XNCR | $18.98 -0.47% -0.47% 470K
|
Health Technology
|
| O: -0.66%
H: 4.19%
C: 3.13%
MOR | News | $18.02 -0.11% -0.11% 590K
|
Health Technology
|
| O: 0.22%
H: 0.22%
C: -0.93%
INCY | $52.82 0.19% 0.19% 1.8M
|
Health Technology
|
| O: 0.03%
H: 1.47%
C: -0.72%
year update financial results
REGENXBIO Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlights
Published: 2024-02-27 (Crawled : 21:00) - prnewswire.com
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.05%
H: 0.06%
C: -0.95%
RGNX | News | $16.08 -5.58% -5.91% 560K
|
Health Technology
|
| O: -5.04%
H: 5.42%
C: 4.68%
year financial results
Novartis presents new 48-week results from Phase III APPLY-PNH trial showing sustained efficacy and long-term safety of Fabhalta® (iptacopan) in adults with paroxysmal nocturnal hemoglobinuria (PNH)
Published: 2023-12-11 (Crawled : 01:00) - globenewswire.com
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.75%
H: 0.55%
C: 0.27%
fabhalta novartis trial results
S&P Dow Jones Indices Announces Dow Jones Sustainability Indices 2023 Review Results
Published: 2023-12-08 (Crawled : 23:00) - prnewswire.com
TCEHY | $38.21 0.04% 1.9M
|
Information
| Email alert
Add to watchlist
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
| Email alert
Add to watchlist
TCTZF | $38.248 2.11% 12K
|
Technology Services
| Email alert
Add to watchlist
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
| Email alert
Add to watchlist
AZNCF | $140.15 -4.19% 560
|
Health Technology
| Email alert
Add to watchlist
SPGI | $413.37 0.31% 0.0% 1.1M
|
Commercial Services
| Email alert
Add to watchlist
DNOW | $14.73 0.75% 0.0% 870K
|
Distribution Services
| Email alert
Add to watchlist
jones review results
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides Business Update
Published: 2023-11-28 (Crawled : 21:00) - globenewswire.com
ALVO | $12.9 0.78% 0.78% 90K
|
n/a
|
| O: 1.02%
H: 0.0%
C: -5.05%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.18%
H: 0.12%
C: -0.16%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
ABBV | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.73%
H: 0.78%
C: 0.35%
KMDA | $5.075 -0.1% -0.1% 6.5K
|
Health Technology
|
| O: 0.73%
H: 0.0%
C: -1.04%
business update financial results
Genmab Announces Financial Results for the First Nine Months of 2023
Published: 2023-11-07 (Crawled : 16:00) - globenewswire.com
GNMSF | $281.02 3.83% 210
|
Health Technology
|
| O: 0.39%
H: 4.92%
C: 1.52%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.24%
H: 0.18%
C: 0.16%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
ABBV | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.28%
H: 0.0%
C: 0.0%
GMAB | $28.32 -0.74% -0.74% 240K
|
Health Technology
|
| O: 0.24%
H: 3.44%
C: 2.07%
BNTX | $86.19 -0.24% -0.24% 580K
|
Health Technology
|
| O: -0.35%
H: 3.09%
C: 3.03%
financial results
Scinai Immunotherapeutics Innovative Plaque Psoriasis Treatment Shows Encouraging Preclinical Results
Published: 2023-09-13 (Crawled : 20:00) - globenewswire.com
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.28%
H: 1.0%
C: 0.76%
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.77%
H: 0.43%
C: -1.27%
psoriasis treatment preclinical results
Sandoz announces positive results from Mylight Phase lll study for biosimilar aflibercept
Published: 2023-08-15 (Crawled : 06:00) - globenewswire.com
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.32%
H: 0.18%
C: -0.44%
biosimilar positive results study
Precision BioSciences Reports Second Quarter 2023 Financial Results and Provides Business Update
Published: 2023-08-04 (Crawled : 12:20) - precisionbiosciences.com
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.38%
H: 0.73%
C: 0.15%
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
DTIL | $10.77 -6.43% -6.87% 71K
|
Health Technology
|
| O: -0.95%
H: 0.0%
C: 0.0%
business update financial results
REGENXBIO Reports Second Quarter 2023 Financial Results and Recent Operational Highlights
Published: 2023-08-02 (Crawled : 20:00) - prnewswire.com
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -1.38%
H: 0.77%
C: 0.7%
RARE | $43.38 -1.65% -1.68% 770K
|
Health Technology
|
| O: 0.0%
H: 0.85%
C: -2.48%
RGNX | News | $16.08 -5.58% -5.91% 560K
|
Health Technology
|
| O: -7.2%
H: 10.26%
C: -0.34%
financial results
Ayala Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-05-23 (Crawled : 17:00) - globenewswire.com
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.22%
H: 0.0%
C: -0.62%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.74%
H: 0.0%
C: -1.22%
ADXS | $0.6455 12.48% 2.3K
|
Health Technology
|
| O: -5.0%
H: 25.0%
C: 25.0%
update pharmaceuticals financial results
Alvotech Reports Financial Results for First three Months of 2023 and Provides Business Update
Published: 2023-05-19 (Crawled : 09:00) - globenewswire.com
ALVO | $12.9 0.78% 0.78% 90K
|
n/a
|
| O: 8.94%
H: 0.0%
C: -7.65%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.36%
H: 1.01%
C: 0.82%
ABBV | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.29%
H: 1.35%
C: 0.87%
REGN | $893.66 -0.84% -0.84% 450K
|
Health Technology
|
| O: 0.64%
H: 1.56%
C: 0.9%
KMDA | $5.075 -0.1% -0.1% 6.5K
|
Health Technology
|
| O: 2.31%
H: 1.86%
C: -0.2%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.09%
H: 0.64%
C: -0.45%
business update financial results
Genmab Announces Financial Results for the First Quarter of 2023
Published: 2023-05-10 (Crawled : 14:20) - globenewswire.com
GNMSF | $281.02 3.83% 210
|
Health Technology
|
| O: 0.92%
H: 0.54%
C: -0.64%
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.24%
H: 0.0%
C: 0.0%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -1.03%
H: 0.26%
C: 0.01%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.09%
H: 0.48%
C: 0.28%
ABBV | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.21%
H: 0.32%
C: -0.07%
GMAB | $28.32 -0.74% -0.74% 240K
|
Health Technology
|
| O: 0.15%
H: 2.12%
C: 1.79%
BNTX | $86.19 -0.24% -0.24% 580K
|
Health Technology
|
| O: -1.6%
H: 1.64%
C: -0.39%
financial results
Precision BioSciences Reports First Quarter 2023 Financial Results and Provides Business Update
Published: 2023-05-09 (Crawled : 12:00) - precisionbiosciences.com
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: -2.35%
H: 1.06%
C: 0.48%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.38%
H: 0.39%
C: 0.18%
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.22%
H: 0.89%
C: -0.79%
DTIL | $10.77 -6.43% -6.87% 71K
|
Health Technology
|
| O: -2.94%
H: 5.45%
C: 3.03%
business update financial results
REGENXBIO Reports First Quarter 2023 Financial Results and Recent Operational Highlights
Published: 2023-05-03 (Crawled : 00:00) - biospace.com/
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.96%
H: 0.0%
C: 0.0%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.55%
H: 0.68%
C: 0.33%
QURE | $4.71 0.86% 0.85% 440K
|
Health Technology
|
| O: 0.4%
H: 3.8%
C: 2.37%
RARE | $43.38 -1.65% -1.68% 770K
|
Health Technology
|
| O: 0.92%
H: 3.17%
C: 1.0%
RGNX | News | $16.08 -5.58% -5.91% 560K
|
Health Technology
|
| O: 0.05%
H: 5.85%
C: 3.74%
financial results
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Update
Published: 2023-03-09 (Crawled : 12:00) - precisionbiosciences.com
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: -5.6%
H: 1.19%
C: 1.19%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -3.04%
H: 0.16%
C: -0.9%
DTIL | $10.77 -6.43% -6.87% 71K
|
Health Technology
|
| O: 0.87%
H: 2.59%
C: -12.07%
year financial update results
TScan Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Upcoming Milestones
Published: 2023-03-08 (Crawled : 14:00) - biospace.com/
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: 2.45%
H: 0.0%
C: 0.0%
TCRX | News 0 d | $6.9 2.22% 2.17% 250K
|
Professional, Scientific, and T...
|
| O: -2.73%
H: 6.07%
C: 3.43%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.4%
H: 0.32%
C: -0.42%
year therapeutics financial results
BeiGene Reports Fourth Quarter and Full Year 2022 Financial Results
Published: 2023-02-27 (Crawled : 14:00) - biospace.com/
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.64%
H: 0.01%
C: -0.72%
BGNE S | $131.94 0.06% 0.06% 130K
|
Health Technology
|
| O: -2.82%
H: 5.13%
C: 3.11%
year financial results
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.